Drug Monitoring, Opioids Panel, Quantitative, Urine
Test Code
39012
80348, 80363, 80354, 80356, 80358, 80323, 80361, 80365, 80372, 80373 (HCPCS: G0481)
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
Clinical Significance
Drug Monitoring, Opioids Panel, Quantitative, Urine - Monitoring of parent compounds and their metabolites in urine. The results of this test are used in specific treatment programs to determine compliance with prescribed dosing schedules.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Buprenorphine, Codeine, Dextromethorphan, Dextrorphan, EDDP, Fentanyl, Heroin Metabolite, Hydrocodone, Hydromorphone, Methadone, Mitragynine, Morphine, Naloxone, Norbuprenorphine, Norfentanyl, Norhydrocodone, Noroxycodone, Nortapentadol, O-desmethyltramadol, Oxycodone, Oxymorphone, Tapentadol, Tramadol
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Buprenorphine, Codeine, Dextromethorphan, Dextrorphan, EDDP, Fentanyl, Heroin Metabolite, Hydrocodone, Hydromorphone, Methadone, Mitragynine, Morphine, Naloxone, Norbuprenorphine, Norfentanyl, Norhydrocodone, Noroxycodone, Nortapentadol, O-desmethyltramadol, Oxycodone, Oxymorphone, Tapentadol, Tramadol
Methodology
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
| Buprenorphine | <2 ng/mL |
| Norbuprenorphine | <2 ng/mL |
| Naloxone | <2 ng/mL |
| Fentanyl | <0.5 ng/mL |
| Norfentanyl | <0.5 ng/mL |
| Heroin Metabolite | <10 ng/mL |
| Methadone | <100 ng/mL |
| EDDP | <100 ng/mL |
| Dextromethorphan | <20 ng/mL |
| Dextrorphan | <20 ng/mL |
| Mitragynine | <2 ng/mL |
| Codeine | <50 ng/mL |
| Hydrocodone | <50 ng/mL |
| Hydromorphone | <50 ng/mL |
| Norhydrocodone | <50 ng/mL |
| Morphine | <50 ng/mL |
| Oxycodone | <50 ng/mL |
| Oxymorphone | <50 ng/mL |
| Noroxycodone | <50 ng/mL |
| Tapentadol | <50 ng/mL |
| Nortapentadol | <50 ng/mL |
| Tramadol | <100 ng/mL |
| O-desmethyltramadol | <100 ng/mL |
Alternative Name(s)
Opiates
Preferred Specimen(s)
3 mL random urine
Minimum Volume
2 mL
Transport Container
Plastic urine container
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 14 days
- Frozen: 21 days
Reject Criteria
Preserved samples
Setup Schedule
3 mL random urine
2 mL
Plastic urine container
Room temperature
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 21 days
Refrigerated: 14 days
Frozen: 21 days
Preserved samples